| DATIA's New Webinar Series |
 |
 |
 |
DATIA Webinar Series
**All Webinars To Begin At 2PM EST**
Purchase an archived DATIA webinar here!
Register Today! DATIA is pleased to present our new webinar line up for 2011. Don't miss out on this educational opportunity! DATIA's webinars provide you with quality education from the comfort of your own computer. No travel, no time away from the office, and the opportunity to learn for the benefit of you and your clients. Webinars will be offered monthly with archived versions available to those who registered. Each webinar will last 1 hour.
**All Webinars To Begin At 2PM EST** Click here to view archived webinars from 2010 and 2011 (simply click on the title of each webinar you would like to purchase)
Webinar Fees Attendee The rate for participation in a DATIA webinar is $49. That is an exceptional value for education on the topics of importance to you and your business. The best part is that the fee is per connection, so go ahead, register today, put your phone on speaker during the webinar, and have a lunchtime educational session in your office with all of your office mates. Each webinar is interactive so you will have the opportunity to submit questions to the presenter and receive answers online and by phone. It’s just like being there live with the speaker.
Sponsor Are you looking for an opportunity to get your company noticed and to make a mark in the industry? Then look no further than signing up to sponsor an upcoming DATIA webinar. For the low webinar sponsor fee of $750 you will receive promotion by the following means:
Webinar Schedule**All Webinars To Begin At 2PM EST**
March 14, 2012
May 9, 2012
June 13, 2012
July 11, 2012
August 8, 2012
September 12, 2012
October 10, 2012
November 14, 2012
December 12, 2012 Webinar Information Starting a Drug and Alcohol Testing Business Presented By: Joe Reilly
An introductory workshop for those just getting started or those interested in starting a new drug testing business. This session will cover business basics, insurance, licenses, business tools, getting vendors and getting customers for a new drug & alcohol testing business. Learn how to set up your operation, what products to sell, what markets to seek, what technologies you need and much more. Get first hand advice on what to do and what not to do.
Joe Reilly entered the world of drug testing in 1993, he is well known throughout the industry and considered an expert on workplace drug testing issues. Joe served for nine years on the DATIA Board of Directors and served as Chairman of the Board from 2004–2008. Joe sold his business Florida Drug Screening in 2007 to CBC Companies (Columbus, Ohio), he retired from the firm in 2009 and currently continues to invest in and manage both commercial and residential properties in Central Florida. He is also active in assisting buyers and sellers in the drug testing industry work through the merger and/or acquisition process. Student Drug Testing Presented By: Elaine Taule
Objectives:
Elaine Taule is the President and CEO of NMS Management Services, Inc., a full-service consulting company for drug and alcohol testing programs that was founded in 1989. Over the past 20 years, Ms. Taule has been assisting employers and schools with drug and alcohol testing program development and implementation. In 2008 Ms. Taule applied for and was awarded the Random Student Drug Testing Grant for the School District of Palm Beach County. The award was provided by the U.S. Department of Education. Elaine serves on the Board of Directors for DATIA. Synopsis and Objectives: Introduce attendees to federally regulated and non-regulated drugs available on the internet. To include the many synthetic marijuana metabolites, bath salts, methamphetamine like drugs, plants and other products. How do these compounds impact the user. Discuss pros and cons of including these in a company’s testing panel. Updates on where they can be tested and cost of analysis.
1. Learn more about new drugs available on the internet
Since 1980, Pat Pizzo has served as a senior technical manager and vice president of operations at Alere Toxicology and is currently the Director of Toxicology. Before coming to Alere, she worked as a chemist in the Toxicology Lab for the Federal Bureau of Investigation in Washington, DC. Having been in the industry for over 40 years, Ms. Pizzo is an active member of, advisor to, and participant in many technical and professional organizations of forensic toxicology. She is a former member of the Federal Drug Testing Advisor Board and in that capacity advises SAMHSA on drug policies. As an inspector for the National Laboratory certification Program and the College of American Pathologist Forensic Urine Drug Testing Program she is often called on to perform laboratory inspections. She also serves as a consultant for many national companies. Ms. Pizzo is a Board Certified Forensic Examiner and has been certified as an expert witness in Federal and State courts and has testified throughout the country. She has been a guest speaker on many radio talk shows and featured in newspapers and magazines. She has authored and co-authored several articles that have appeared in the United States and abroad. Many of the policies in effect today utilized by others have been a direct result from her expertise in this field. This webinar is ideal for preparing for audits by regulators, service agents or your very own clients. This session will help you understand what auditors are really looking for and how to view files and procedures from their perspective. We will also discuss how to set the stage for a successful audit and how to be "audit ready" at all times! Lisa C. Ruehle, PHR, C-DER Evidence biochip array technology performs simultaneous detection of multiple analytes from a single sample. Simultaneous competitive chemiluminescent immunoassays are employed for the detection of drugs on the biochip with matrix dedicated assay kits. The fully automated bench top analyzer Evidence MultiStat has been designed to bring this technology near the point of application. The time to analysis is reduced, but still laboratory standard results are provided. Test results are produced after 30 minutes of sampling.
- Biochip array technology for extensive multiplex screening of drugs made simple. - Rapid simultaneous detection of amphetamine, methamphetamine, methylenedioxymethamphetamine (MDMA), barbiturates, benzodiazepines, buprenorphine, cannabinoids, cocaine metabolite (benzoylecgonine), methadone, opiates, phencyclidine, tricyclic antidepressants (TCAs). - Fully automated bench top biochip system for point of application. Self contained sealed unit for minimum user input. - Matrix specific assay kits (urine, whole blood). - The system allows simultaneous assessment of control material alongside the sample for immediate result validation. - Flexibility for the incorporation of new emerging drugs.
2000 first class honours degree in Biochemistry (University of Dundee). 2004 PhD in the Department of Molecular and Cellular Pathology (University of Dundee). The research work focused on determining the role of bile acid reflux in the development of oesophageal cancer. Postdoctoral research training fellowship investigating the regulation of cytokines in the immune system by mitogen and stress activated protein kinase. Working in the toxicology field at Randox Laboratories for the past four years with involvement in the validation and release of drugs of abuse assays using Evidence Biochip Array Technology to test for drugs of abuse in a variety of matrices. Currently leading a group of scientists working in this area. Presented By: John Baxter
John Baxter founded Baxter Assistance Services, Inc. in December 1989. His company is a provider of Employee Assistance Program, Drug Free Workplace Program and Substance Abuse Professional services for employers. John also provides individual chemical dependency counseling. He is a Certified Addiction Counselor II, a Licensed Chemical Dependency Counselor, and a Substance Abuse Professional.
This session begins with an overview of the history and rational of the return to duty process and why it is not to be considered "clinical" or a counseling process, but as a "safety" issue. John will walk participants through the return to duty process and the role that the Substance Abuse Professional plays in this process. Pros and cons of the return to duty process will be discussed. Understand the difference between Mandated and Non-Mandated Testing
Dr. Charles Prezzia is currently certified by both MROCCC and AAMRO as well as serving on the Board of Directors of MROCC. In addition to having been an MRO for 20 years, he also was responsible for both the non-regulated drug testing and safety-related medical exam programs at USX/U.S. Steel for 11 years. He currently serves as a consulting physician to Marathon Oil Corporation, Elliott Group, Farmland Foods, CorVel, and ATI-Allegheny Ludlum as well as other entities. His services are available on an international basis. For more information, see www.occusystems.com
According to Statistics from the 2009 National Survey on Drug Use and Health published by the US Department of Health & Human Services, nearly 22 million people, in the US, aged 12 or older admitted to be current illicit drug users; it is estimated that illicit drug use in the workplace costs employers $140 billion annually in lost productivity, thefts, absenteeism and accidents. In addition, approximately 17 million Americans have a serious problem with alcohol; the National Institute on Alcohol Abuse and Alcoholism estimates that alcohol abuse costs the US an estimated $185 billion annually. Help reduce the impact of drug and alcohol abuse on your business; in this course, you will learn: - How to understand the dangers of abuse in the workplace - How to recognize warning signs - How to approach employees regarding suspected abuse - How to prevent and mitigate potential incidents
Amy Evans is the Business Development Manager of Training for Lifeloc Technologies, a leading manufacturer of Workplace breath alcohol testers and developer of alcohol training programs for DOT mandated drug and alcohol testing. Amy has been with Lifeloc since 2004 and has developed successful alcohol training programs targeted at a wide range of audiences including DOT mandated, law enforcement and corrections. She holds two BAs from the University of Colorado and a MBA from Capella University. The Impact on Human Resources and the DER from Errors in the Testing Process Presented By: Shannon Lalley More information coming soon.
|
 Contact Us
info@datia.org 800-355-1257
1325 G Street, NW Suite500 #5001 Washington, DC 20005 Fax: 202-315-3579
1325 G Street, NW Suite 500#5001 Washington, DC 20005
Fax: 202-315-3579
|